Topline results expected in the third quarter of 2025.SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ...

The diagnosis-first methodology supports both clinical and revenue cycle teams by ensuring precise documentation.

A retrospective review shows that dermatologic patients treated with mycophenolate mofetil face a significantly lower incidence of malignancy than transplant recipients.

Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based ...

Billed as a first instance of payer integration with a patient portal, the health plan now enables members who are already MyChart users to manage both their clinical care and insurance details in the ...

July 21, 2025 – hellocare.ai, the leading AI-assisted virtual care delivery and patient engagement platform transforming ...